Enhanced liver fibrosis test

DIAGNOSTIC_TEST2 trials

Sponsors

Maja Thiele, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions

FibrosisLiver Diseases, AlcoholicNon-Alcoholic Fatty Liver Disease

Unknown Phase

Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers

RecruitingNCT03308916

Maja ThieleFibrosis, Liver Diseases, Alcoholic

Start: 2017-10-06End: 2035-10-30Target: 6500Updated: 2022-09-01

The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study

CompletedNCT05712603

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Non-Alcoholic Fatty Liver Disease

Start: 2022-10-01End: 2024-10-15Updated: 2024-10-22

Related Papers

Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the community

Journal of Hepatology2025-07-045 citations

Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease

Journal of Hepatology2023-04-21176 citations